Vanessa Gill
Director of Analytical Development and CMC,
ProtaGene
Vanessa Gill is the Director of Analytical Development and CMC at ProtaGene US. She has over 12 years of experience in the biopharmaceutical industry, specializing in biologics characterization and analytical method development from early discovery to late-stage development. As Director at ProtaGene, she manages the CMC team and provides strategic leadership and direction for phase-appropriate analytical development activities. Her expertise spans a broad range of analytical approaches for extended characterization of complex biologics, including mass spectrometry, chromatography, and biophysical techniques. Dr. Gill holds a doctoral degree in Chemistry.
Sessions
-
26-Sep-2025Spotlight Presentation: Analytical Characterization of Oligonucleotides
-
25-Sep-2025Spotlight Presentation: Analytical Characterization of Biotherapeutics
-
30-Apr-2026Spotlight Presentation: Analytical Characterization of Oligonucleotides
-
02-Sep-2026Spotlight Presentation: Advanced Analytical Solutions for Antibodies: Product and Impurity Characterization


